Dr. Ling Su named new DIA board president

09-Aug-2012 - United Kingdom

DIA announced the appointment of  Dr Ling Su as President of the DIA Board of Directors.

Dr. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai. Dr. Su brings more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigilance, pharmacoepidemiology, and outcomes research.

Dr. Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances